These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 2329263)
1. A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemia. Lissoni P; Mainini E; Mazzi C; Cattaneo G; Barni S J Endocrinol Invest; 1990 Feb; 13(2):85-9. PubMed ID: 2329263 [TBL] [Abstract][Full Text] [Related]
2. Basal, pulsatile, entropic, and 24-hour rhythmic features of secondary hyperprolactinemia due to functional pituitary stalk disconnection mimic tumoral (primary) hyperprolactinemia. Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F J Clin Endocrinol Metab; 2001 Apr; 86(4):1562-7. PubMed ID: 11297584 [TBL] [Abstract][Full Text] [Related]
3. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy. Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107 [TBL] [Abstract][Full Text] [Related]
4. Amplification of nocturnal melatonin secretion in women with nocturnal hyperprolactinemia. Okatani Y; Okada M; Sagara Y Asia Oceania J Obstet Gynaecol; 1992 Sep; 18(3):289-97. PubMed ID: 1449428 [TBL] [Abstract][Full Text] [Related]
5. [Melatonin radioimmunoanalysis: evaluation of the pineal function in hyperprolactinemic male rats and controls]. Villanúa MA; Esquifino AI; Tresguerres JA Rev Esp Fisiol; 1986 Jun; 42(2):227-32. PubMed ID: 3749580 [TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effects of melatonin on the development of 17-beta-estradiol induced prolactinoma in relation to plasma prolactin and peroxidative lipid contents]. Gao L; Xu JP; Shan HM; Zhang R; Xu RK Sheng Li Xue Bao; 2001 Jun; 53(3):165-9. PubMed ID: 12589398 [TBL] [Abstract][Full Text] [Related]
8. Prolactin-releasing and release-inhibiting factor activities in the bovine, rat, and human pineal gland: in vitro and in vivo studies. Blask DE; Vaughan MK; Reiter RJ; Johnson LY; Vaughan GM Endocrinology; 1976 Jul; 99(1):152-62. PubMed ID: 7446 [TBL] [Abstract][Full Text] [Related]
10. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia. Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032 [TBL] [Abstract][Full Text] [Related]
11. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia]. Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023 [TBL] [Abstract][Full Text] [Related]
12. Ropinirole for the Treatment of Hyperprolactinemia: A Dose-Escalation Study of Efficacy and Tolerability. Heneghan LJ; Tsang A; Dimino C; Khandji AG; Panigrahi SK; Page-Wilson G J Clin Endocrinol Metab; 2024 Jan; 109(2):e667-e674. PubMed ID: 37715962 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic effects of Schisandra chinensis on the hyperprolactinemia in rat. Hong SH; Li M; Jeung EB; Lee GS; Hong EJ; Choi YW; An BS Int J Oncol; 2017 Apr; 50(4):1448-1454. PubMed ID: 28259983 [TBL] [Abstract][Full Text] [Related]